| 000 | 01731 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516103733.0 | ||
| 264 | 0 | _c20121218 | |
| 008 | 201212s 0 0 eng d | ||
| 022 | _a1945-7197 | ||
| 024 | 7 |
_a10.1210/jc.2012-2218 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _avan Lierop, A H | |
| 245 | 0 | 0 |
_aCirculating sclerostin levels are decreased in patients with endogenous hypercortisolism and increase after treatment. _h[electronic resource] |
| 260 |
_bThe Journal of clinical endocrinology and metabolism _cOct 2012 |
||
| 300 |
_aE1953-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdaptor Proteins, Signal Transducing |
| 650 | 0 | 4 | _aAdrenalectomy |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBone Morphogenetic Proteins _xblood |
| 650 | 0 | 4 |
_aBone Remodeling _xphysiology |
| 650 | 0 | 4 |
_aCollagen Type I _xblood |
| 650 | 0 | 4 |
_aCushing Syndrome _xmetabolism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFibroblast Growth Factor-23 |
| 650 | 0 | 4 |
_aFibroblast Growth Factors _xblood |
| 650 | 0 | 4 | _aGenetic Markers |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydrocortisone _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOsteocytes _xphysiology |
| 650 | 0 | 4 |
_aPeptide Fragments _xblood |
| 650 | 0 | 4 |
_aPeptides _xblood |
| 650 | 0 | 4 |
_aProcollagen _xblood |
| 700 | 1 | _avan der Eerden, A W | |
| 700 | 1 | _aHamdy, N A T | |
| 700 | 1 | _aHermus, A R | |
| 700 | 1 | _aden Heijer, M | |
| 700 | 1 | _aPapapoulos, S E | |
| 773 | 0 |
_tThe Journal of clinical endocrinology and metabolism _gvol. 97 _gno. 10 _gp. E1953-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1210/jc.2012-2218 _zAvailable from publisher's website |
| 999 |
_c21984308 _d21984308 |
||